• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   DSpace@Medipol
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • Scopus İndeksli Yayınlar Koleksiyonu
  • View Item
  •   DSpace@Medipol
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • Scopus İndeksli Yayınlar Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Systematic evaluation of promising clinical trials-gene silencing for the treatment of glioblastoma

Thumbnail

View/Open

Tam Metin / Full Text (497.2Kb)

Access

info:eu-repo/semantics/openAccess

Date

2019

Author

Karaarslan, Numan
Yılmaz, İbrahim
Özbek, Hanefi
Çalışkan, Tezcan
Topuk, Savaş
Yaşar Şirin, Duygu
Ateş, Özkan

Metadata

Show full item record

Citation

Karaarslan, N., Yılmaz, İ., Özbek, H., Çalışkan, T., Topuk, S. Yaşar Şirin, D. ve Ateş, Ö. (2019). Systematic evaluation of promising clinical trials-gene silencing for the treatment of glioblastoma. Turkish Neurosurgery, 29(3), 328-334. https://dx.doi.org/10.5137/1019-5149.JTN.22467-18.3

Abstract

AIM: To systematically investigate the role of artificial small interfering RNA (SiRNA) molecules in glioblastoma treatment and to give a detailed overview of the literature concerning studies performed in this field worldwide in the last 31 years. MATERIAL and METHODS: Articles about clinical trials conducted between December 1, 1949 and November 8, 2017, were identified from the Cochrane Collaboration, the Cochrane Library, Ovid MEDLINE, ProQuest, the National Library of Medicine, and PubMed electronic databases, using the terms "post transcriptional gene silencing," "small interfering RNA," "siRNA," and "glioblastoma," either individually or combined ("OR" and "AND"), without language and country restrictions. Articles that met the examination criteria were included in the study. After descriptive statistical evaluation, the results were reported in frequency (%). RESULTS: After scanning 2.752 articles, five articles were found that met the research criteria. Examination of full texts of the five identified articles provided no sufficient evidence for research conducted with regard to the use of gene silencing via siRNAs in glioblastoma treatment. CONCLUSION: To be able to evaluate the clinical use of siRNAs, there is an urgent need for in vivo studies and for trials with randomized, controlled, and clinical designs that provide long-term functional outcomes.

WoS Q Kategorisi

Q4

xmlui.dri2xhtml.METS-1.0.item-scopusquality

Q3

Source

Turkish Neurosurgery

Volume

29

Issue

3

URI

https://dx.doi.org/10.5137/1019-5149.JTN.22467-18.3
https://hdl.handle.net/20.500.12511/4008

Collections

  • Makale Koleksiyonu [3454]
  • PubMed İndeksli Yayınlar Koleksiyonu [3772]
  • Scopus İndeksli Yayınlar Koleksiyonu [5815]
  • TR-Dizin İndeksli Yayınlar Koleksiyonu [2169]
  • WoS İndeksli Yayınlar Koleksiyonu [5982]



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 




| Guide | Contact |

DSpace@Medipol

by OpenAIRE
Advanced Search

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsInstitution AuthorORCIDTitlesSubjectsTypeLanguageDepartmentCategoryWoS Q ValueScopus Q ValuePublisherAccess TypeThis CollectionBy Issue DateAuthorsInstitution AuthorORCIDTitlesSubjectsTypeLanguageDepartmentCategoryWoS Q ValueScopus Q ValuePublisherAccess Type

My Account

LoginRegister

Statistics

View Google Analytics Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide || Library || İstanbul Medipol University || OAI-PMH ||

Kütüphane ve Dokümantasyon Daire Başkanlığı, İstabul, Turkey
If you find any errors in content, please contact: [email protected]

Creative Commons License
DSpace@Medipol by İstanbul Medipol University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@Medipol:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.